Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Vera Therapeutics Inc
VERACurrent price
46.26 USD
-3.03 USD (-6.15%)
Last closed
49 USD
Company
veratx.com
ISIN
US92337R1014
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
3 045 207 808 USD
Yield for 12 month
+237.91 %
1Y
3Y
5Y
10Y
15Y
VERA
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase III clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis that is in Phase II clinical trial. It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California. Address: 8000 Marina Boulevard, Brisbane, CA, United States, 94005
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
63.91 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
+1 862 000 USD
Last Year
+846 000 USD
Current Quarter
–
Last Quarter
–
Key Figures VERA
1 year
3 years
5 years
10 years
EBITDA
-90 727 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-33.37 %
PEG Ratio
–
Return On Equity TTM
-65.11 %
Wall Street Target Price
63.91 USD
Revenue TTM
–
Book Value
5.25 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-2.19 USD
Diluted Eps TTM
-2.19 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics VERA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History VERA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation VERA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-3.5968
Price Book MRQ
9.2879
Financials VERA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators VERA
For 52 weeks
12.28 USD
50.78 USD
50 Day MA
41.53 USD
Shares Short Prior Month
6 170 825
200 Day MA
40.16 USD
Short Ratio
8.96
Shares Short
6 189 776
Short Percent
15.88 %
BeatStart